Josep Jové

474 total citations
17 papers, 302 citations indexed

About

Josep Jové is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Josep Jové has authored 17 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 2 papers in Surgery. Recurrent topics in Josep Jové's work include Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (5 papers). Josep Jové is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (5 papers). Josep Jové collaborates with scholars based in Spain, United States and Switzerland. Josep Jové's co-authors include Jordi Bruna, Lucía Vaquero, Marta Simó, Antoni Rodrı́guez-Fornells, Pablo Ripollés, Felipe Cardenal, Arturo Navarro-Martín, James C. Root, Tim A. Ahles and E. Verger and has published in prestigious journals such as Journal of Clinical Oncology, Radiotherapy and Oncology and Journal of Thoracic Oncology.

In The Last Decade

Josep Jové

17 papers receiving 301 citations

Peers

Countries citing papers authored by Josep Jové

Since Specialization

Citations

This map shows the geographic impact of Josep Jové's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Jové with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Jové more than expected).

Fields of papers citing papers by Josep Jové

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Jové. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Jové. The network helps show where Josep Jové may publish in the future.

Co-authorship network of co-authors of Josep Jové

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Jové. A scholar is included among the top collaborators of Josep Jové based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Jové. Josep Jové is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Psychometric validation of the Spanish version of the Expanded Prostate Cancer Index Composite-26 2023 ·World Journal of Urology ·(unknown), Olatz Garín, (unknown), Josep Jové, (unknown), F. Ferrer, Cristina Gutiérrez, Ferrán Guedea, A. Boladeras, Lluís Fumadó, A Soler Roselló, (unknown), Pilar Samper, Àngels Pont, Montse Ferrer	1
2	PCN19 Effectiveness and Medical Costs of Abiraterone Acetate Versus Docetaxel in First-LINE Treatment of Metastatic Castration-Resistant Prostate Cancer from the French Nationwide Claims Database (SNDS): Camerra Study 2020 ·Value in Health ·Nicolas H. Thurin, (unknown), Marine Gross‐Goupil, (unknown), Xavier Rébillard, (unknown), (unknown), (unknown), (unknown), S. Lamarque, Josep Jové, C. Droz‐Perroteau, Nicholas Moore, Gérard de Pouvourville, Patrick Blin	2
3	Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes 2019 ·Clinical & Translational Oncology ·Carmen González‐San Segundo, Josep Jové, A. Zapatero, (unknown), (unknown), (unknown), J. Mengual, Antonio Gómez‐Caamaño, Alfonso Gómez‐Iturriaga, Carmen Vallejo, I. Henrı́quez, (unknown), Joey Clemente, (unknown), (unknown), (unknown), E. Villafranca, (unknown), J. López Torrecilla	5
4	Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database 2018 ·Clinical & Translational Oncology ·A. Hervás, (unknown), Carlos González, Josep Jové, (unknown), (unknown), E. Villafranca, J. Mengual, Víctor Manuel Becerra‐Muñoz, I. Henrı́quez, José Muñóz, (unknown), Joey Clemente	3
5	Clinical Audit of the Radiotherapy Process in Rectal Cancer: Clinical Practice Guidelines and Quality Certification Do Not Avert Variability in Clinical Practice 2018 ·Translational Oncology ·(unknown), E Canals, Diego Jurado‐Bruggeman, (unknown), (unknown), Josep Jové, (unknown), (unknown), Joaquı́n Molero Mesa, (unknown), (unknown), Luisa Aliste, Abiguei Torrents, Ferrán Guedea, Josep M. Borràs	4
6	Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database 2017 ·Clinical & Translational Oncology ·A. Hervás, Antonio Gómez‐Caamaño, (unknown), Alfonso Gómez‐Iturriaga, (unknown), Josep Jové, J. Mengual, Carmen González‐San Segundo, José Muñóz	5
7	Brain functional connectivity in lung cancer population: an exploratory study 2017 ·Brain Imaging and Behavior ·Marta Simó, Xavier Rifà‐Ros, Lucía Vaquero, Pablo Ripollés, Núria Cayuela, Josep Jové, Arturo Navarro-Martín, F. Cardenal, Jordi Bruna, Antoni Rodrı́guez-Fornells	31
8	Longitudinal Brain Changes Associated with Prophylactic Cranial Irradiation in Lung Cancer 2016 ·Journal of Thoracic Oncology ·Marta Simó, Lucía Vaquero, Pablo Ripollés, (unknown), Josep Jové, Arturo Navarro-Martín, Felipe Cardenal, Jordi Bruna, Antoni Rodrı́guez-Fornells	51
9	The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort 2016 ·Clinical & Translational Oncology ·Alfonso Gómez‐Iturriaga, Alejandro Pérez Cabeza, (unknown), Josep Jové, (unknown), (unknown), J. Mengual, I. Henrı́quez, José Muñóz, A. Hervás, Carmen González San Segundo	3
10	OC-0342: Chemoradiotherapy in high-risk prostate cancer (QRT SOGUG trial): Preliminary report 2016 ·Radiotherapy and Oncology ·P. Foro, Xavier Maldonado, Marta Bonet, Josep Jové, Á. Rovirosa, (unknown), (unknown), Gemma Sancho, (unknown), M. Mira, (unknown), M. Algara, Joan Carles	3
11	Brain damage following prophylactic cranial irradiation in lung cancer survivors 2015 ·Brain Imaging and Behavior ·Marta Simó, Lucía Vaquero, Pablo Ripollés, Josep Jové, Rafael Fuentes, Felipe Cardenal, Antoni Rodrı́guez-Fornells, Jordi Bruna	26
12	Prevalence of ROS1 translocation, HER2, and BRAF mutations in a cohort of advanced Non-Small Cell Lung Cancer (NSCLC) patients (p) triple negative (TN). 2015 ·Journal of Clinical Oncology ·Enric Carcereny, Anna Estival, (unknown), (unknown), Teresa Morán, (unknown), (unknown), (unknown), Josep Jové, Cristina Bugés, Vanesa Quiroga, (unknown), (unknown), (unknown), (unknown), (unknown), Núria Pardo, Alberto Indacochea, (unknown), Rafael Rosell	2
13	Cognitive and Brain Structural Changes in a Lung Cancer Population 2014 ·Journal of Thoracic Oncology ·Marta Simó, James C. Root, Lucía Vaquero, Pablo Ripollés, Josep Jové, Tim A. Ahles, Arturo Navarro-Martín, Felipe Cardenal, Jordi Bruna, Antoni Rodrı́guez-Fornells	89
14	Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer 2011 ·Lung Cancer ·Felipe Cardenal, (unknown), Teresa Morán, Josep Jové, Ernest Nadal, Ruth Porta, Josep María Macias i Solé, (unknown), Ramón Palmero, Rafael Fuentes, (unknown), (unknown), (unknown)	15
15	Validation of the new graded prognostic assessment scale for brain metastases: a multicenter prospective study 2011 ·Radiation Oncology ·S. Villà, Damien C. Weber, (unknown), (unknown), Christophe Combescure, Josep Jové, Paloma Puyalto, Patricia Cuadras, Jordi Bruna, E. Verger, Carmen Balañá, Francesc Graus	45
16	Systemic lupus erythematosus in a patient with primary MALT lymphoma of the larynx. 2009 ·PubMed ·(unknown), Blanca Xicoy, Alejandro Olivé, Josep Jové, Josep‐María Ribera, Evarist Feliú	6
17	El análisis modal de fallos y efectos (AMFE) ayuda a aumentar la seguridad en radioterapia 2007 ·Revista de Calidad Asistencial ·(unknown), (unknown), (unknown), (unknown), R. Ballester, (unknown), (unknown), (unknown), Josep Jové, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Evarist Feliú	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact